Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2026-02-06 00:00:00 ET · period of report 2026-02-04 · accession 0001193125-26-041497 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-06 | 2026-01-30 | SNDX | Goldan Keith A. | CFO | J - Other | $8.48 | +1,219 | 93.7K | +1% | +$10.3K |
| D | 2026-02-06 | 2026-02-06 | SNDX | Goldan Keith A. | CFO | S - Sale | $20.62 | -2,082 | 143.8K | -1% | -$42.9K |
| DM | 2026-02-06 | 2026-02-04 | SNDX | Goldan Keith A. | CFO | A - Grant | $0.00 | +52.2K | 115.2K | +83% | $0 |
| D | 2026-02-06 | 2026-02-04 | SNDX | Goldan Keith A. | CFO | A - Grant | $20.43 | +118.0K | 118.0K | New | +$2.41M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-30 | J | A | 1,219 | $8.48 | 93,671 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-06 | S | D | 2,082 | $20.62 | 143,839 | D | — | — | |
| 3 | Common | Common Stock | 2026-02-04 | A | A | 30,750 | $0.00 | 145,921 | D | — | — | (F3) Award of RSUs, representing the right to receive one share of Common Stock for each RSU. The number of shares of Common Stock acquired upon vesting of the RSUs is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee, subject to the Reporting Person's continued service as an employee, consultant, director or officer of the Company. |
| 4 | Common | Common Stock | 2026-02-04 | A | A | 21,500 | $0.00 | 115,171 | D | — | — | (F2) Award of restricted stock units ("RSUs"), representing the right to receive one share of Common Stock for each RSU. One third (1/3rd) of the shares of Common Stock subject to such RSU shall vest annually on the anniversary of the Vesting Commencement Date, during the Reporting Person's continued service as an employee, consultant, director or officer of the Company over the three (3) years following the date of grant, until all of the shares subject to such RSU are fully vested. |
| 5 | Derivative | Stock Options (Right to buy) | 2026-02-04 | A | A | 118,000 | $20.43 | 118,000 | D | $20.43 · — to 2036-02-04 | 118,000 Common Stock | (F5) 1/48th of the shares subject to the option shall vest monthly over a four-year period. |